Related Experiment Video
Updated: May 29, 2026

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
Published on: January 9, 2016
Valuing EQ-5D using time trade-off in France
Julie Chevalier1, Gérard de Pouvourville
1Chair of Health Economics and Management, ESSEC Business School, Avenue Bernard Hirsch, BP 50105, 95021 Cergy-Pontoise Cedex, France. chevalier@essec.fr
This study developed the first French EQ-5D value set using Time Trade-Off (TTO) data from the general public. This enables robust cost-effectiveness analyses in France.
Area of Science:
- Health Economics
- Psychometrics
- Sociology
Background:
- The EQ-5D is a widely used health status measure.
- A French value set for the EQ-5D was previously unavailable.
- This gap limited its application in French health economic evaluations.
Purpose of the Study:
- To derive a French Time Trade-Off (TTO) value set for the EQ-5D.
- To provide a tool for cost-effectiveness analyses in France.
Main Methods:
- Recruited 452 French adults representative of the general population.
- Collected direct health state valuations using TTO.
- Estimated values for all 243 EQ-5D states using mixed-effects models.
- Compared model fits using AIC, MAE, and Pearson correlation.
Main Results:
- 443 respondents completed the study.
- The best-fitting model identified included variables consistent with the UK N3-model.
- A French EQ-5D value set was successfully derived.
Conclusions:
- The derived French EQ-5D value set is based on stated preferences of the French public.
- This value set will facilitate health economic evaluations and cost-effectiveness analyses in France.
- This research addresses a critical need for French-specific EQ-5D valuation data.
Related Concept Videos
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Bioequivalence Data: Statistical Interpretation
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Noncompartmental Analysis: Mean Residence Time
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
Bioequivalence: Overview
Equivalence: In Vitro and In Vivo Bioequivalence

